The impact of host resistance on cumulative mortality and the threshold of herd immunity for SARS-CoV-2
Preprint
- 16 July 2020
- preprint
- other
- Published by Cold Spring Harbor Laboratory
Abstract
It is widely believed that the herd immunity threshold (HIT) required to prevent a resurgence of SARS-CoV-2 is in excess of 50% for any epidemiological setting. Here, we demonstrate that HIT may be greatly reduced if a fraction of the population is unable to transmit the virus due to innate resistance or cross-protection from exposure to seasonal coronaviruses. The drop in HIT is proportional to the fraction of the population resistant only when that fraction is effectively segregated from the general population; however, when mixing is random, the drop in HIT is more precipitous. Significant reductions in expected mortality can also be observed in settings where a fraction of the population is resistant to infection. These results help to explain the large degree of regional variation observed in seroprevalence and cumulative deaths and suggest that sufficient herd-immunity may already be in place to substantially mitigate a potential second wave.Keywords
This publication has 20 references indexed in Scilit:
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Published by Cold Spring Harbor Laboratory ,2020
- SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognitionPublished by Research Square Platform LLC ,2020
- Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort studyThe Lancet Infectious Diseases, 2020
- Age-dependent effects in the transmission and control of COVID-19 epidemicsNature Medicine, 2020
- Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+T cellsPublished by Cold Spring Harbor Laboratory ,2020
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infectionEuropean Journal of Internal Medicine, 2020
- Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individualsPublished by Cold Spring Harbor Laboratory ,2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020